Table 1.
Effects of NSTC on WBV and PV.
| WBV (mPa·s) |
|||||
|---|---|---|---|---|---|
| Group | Dose (mg/kg/d) | 5 s−1 | 50 s−1 | 200 s−1 | PV 120 s−1 (mPa·s) |
| Control | NS | 8.95 ± 2.17 | 6.01 ± 0.92 | 4.68 ± 0.46 | 1.04 ± 0.05 |
| Model | NS | 14.19 ± 2.01## | 7.36 ± 0.86## | 5.67 ± 0.54## | 1.23 ± 0.01## |
| Asp | 100 | 11.08 ± 3.57* | 6.51 ± 1.18 | 5.31 ± 0.81 | 1.18 ± 0.03** |
| NSTC | 400 | 11.25 ± 2.16* | 6.74 ± 0.91 | 5.39 ± 0.33 | 1.21 ± 0.02* |
| NSTC | 800 | 11.09 ± 2.67* | 6.37 ± 0.73* | 5.16 ± 0.37* | 1.20 ± 0.03* |
| NSTC | 1600 | 10.05 ± 2.62** | 6.19 ± 0.54** | 5.12 ± 0.42* | 1.18 ± 0.05* |
Note: All the data were shown as the mean ± SD, n = 10.
NSTC: NaoShuanTong Capsule; ASP: aspirin; WBV: whole blood viscosity; PV: plasma viscosity.
Control group and model group received the same volume of normal saline (NS) for the treatment (10 ml/kg/d). # P < 0.05 and ## P < 0.01 when compared with control group. *P < 0.05 and **P < 0.01 when compared with model group.